Breakthrough Will Allow Cost Effective Production of Smart NanoBattery

mPhase Technologies, Inc. (OTC BB: XDSL.OB - News) mPhase Technologies, Inc. (OTC BB: XDSL.OB - News) today announced that a recent breakthrough that will allow the company to produce their Smart NanoBattery with a much greater cost efficiency has successfully passed rigorous testing.

The improved manufacturing technique will lead to higher yields when the battery is mass produced. The electrowettable reserve battery is being developed under a U.S. Army research grant as a long term continuous power supply for computer memory backup and potential wireless sensor applications.

The ability to maximize the number of usable silicon based electrowettable membranes, which are key components of the Smart NanoBattery during each round of production, is critical to the overall profitability of the company. The recent successful testing has shown that mPhase will be able to yield a very high percentage of the complex silicon membrane once in mass production.

“This breakthrough reaffirms my confidence in the future of the Smart NanoBattery,” said mPhase CEO Ron Durando. “With this accomplishment, we have significantly reduced the manufacturing risk involved in this product. Now it’s just a matter of fitting all the pieces together as we continue with the project and reach the end result of a sales contract with the United States Army.”

The Smart NanoBattery is being developed as part of the Phase II STTR Grant that was awarded by the United States Army in 2008. Upon completion of the development project, mPhase will actively pursue sales contracts with major government organizations, as well as companies that require a battery for industrial applications such as wireless sensors.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.